Postpartum thyroiditis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) |
Sunny Kumar (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Postpartum thyroiditis}} | {{Postpartum thyroiditis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{SKA}} | ||
==Overview== | ==Overview== | ||
Revision as of 01:14, 4 October 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis secondary prevention |
|
Risk calculators and risk factors for Postpartum thyroiditis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
Effective measures for the secondary prevention of Postpartum thyroiditis are same as primary prevention measures.[1]
Secondary Prevention
- Effective measures for the secondary prevention of Postpartum thyroiditis are same as primary prevention measures.
- Studies have shown that 200 µg/day of PO selenomethionine started from 12th week and till the end of postpartum period significantly declines recurrence of postpartum thyroiditis cases.[2]
References
- ↑ Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H (2007). "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies". J Clin Endocrinol Metab. 92 (4): 1263–8. doi:10.1210/jc.2006-1821. PMID 17284630.
- ↑ Reid SM, Middleton P, Cossich MC, Crowther CA (2010). "Interventions for clinical and subclinical hypothyroidism in pregnancy". Cochrane Database Syst Rev (7): CD007752. doi:10.1002/14651858.CD007752.pub2. PMID 20614463.